# Gemcitabine With Abraxane and Other Investigational Therapies in Neoadjuvant Treatment of Pancreatic Adenocarcinoma

> **NCT01470417** · PHASE2 · COMPLETED · sponsor: **University of Florida** · enrollment: 10 (actual)

## Conditions studied

- Pancreatic Cancer

## Interventions

- **DRUG:** Chemotherapy
- **DRUG:** Chemotherapy + ChemoRadiotherapy

## Key facts

- **NCT ID:** NCT01470417
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2014-01
- **Final completion:** 2019-10
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2023-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01470417

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01470417, "Gemcitabine With Abraxane and Other Investigational Therapies in Neoadjuvant Treatment of Pancreatic Adenocarcinoma". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT01470417. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*